Daniel Olson, MD

• Duchossois Center for Advanced Medicine (DCAM) - Hyde Park

Board Certifications

• Medical Oncology
• Internal Medicine

Languages Spoken

• English

Medical Education

• Rush University Medical College

Residency

• Northwestern University Feinberg School of Medicine

Fellowship

• University of Chicago Medicine

• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
• Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Study
• A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
• A Study of ASP1570 Taken by Itself or With Pembrolizumab in Adults With Advanced Solid Tumors

• Aetna HMO (specialists only)
• Aetna POS
• Aetna PPO
• BCBS Blue Precision HMO (specialists only)
• BCBS HMO (HMOI) (specialists only)
• BCBS PPO
• Cigna HMO
• Cigna POS
• Cigna PPO
• CountyCare *see insurance page
• Aetna Better Health *see insurance page
• Medicare
• Multiplan PPO
• PHCS PPO
• United Choice Plus POS/PPO
• United Options (PPO)
• United Select (HMO & EPO) (specialists only)
• United W500 Emergent Wrap
• Aetna Medicare Advantage HMO & PPO
• BCBS Medicare Advantage HMO & PPO
• Humana Medicare Advantage Choice PPO
• Humana Medicare Advantage Gold Choice PFFS
• Humana Medicare Advantage Gold Plus HMO
• United Choice HMO (specialists only)
• University of Chicago Health Plan (UCHP)